Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-4898

LLC-Luc2-GDF15 Cell Line

Home » LLC-Luc2-GDF15 Cell Line

Background of LLC-Luc2-GDF15 Cell Line

GDF15 (Growth Differentiation Factor 15) is a Protein Coding gene it is a member of the transforming growth factor-β (TGF-β) superfamily. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. GDF15 expression and secretion from various organs and tissues is induced in different physiological and pathophysiological states, often linked to mitochondrial stress, leading to highly variable circulating GDF15 levels. Diseases associated with GDF15 include Hyperemesis Gravidarum and Cardiac Rupture. Among its related pathways are Apoptotic Pathways in Synovial Fibroblasts and GPCR Pathway.

Specifications

Catalog Number:
KC-4898
Cell Line Name:
LLC-Luc2-GDF15 Cell Line
Clone Number
Host Cell Line:
LLC-Luc2
Description:
Stable LLC-Luc2 clone expressing exogenous human GDF15 gene
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% DMEM + 20% FBS + 10% DMSO
Propagation Medium:
DMEM + 10% FBS + 1μg/mL Puromycin + 500 μg/mL Hygromycin B
Selection Marker:
Puromycin, Hygromycin B
Morphology:
Epithelial
Subculture:
Split saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:

Cell Line Generation

LLC-Luc2-GDF15 cell line was generated using a lentiviral vector expressing the human GDF15 sequence.

Characterization

Figure 1: Characterization of luciferase expression in LLC-Luc2-GDF15 using the Bright-Glo Detection.

Figure 2: Characterization of human GDF15 overexpression in the LLC-Luc2-GDF15 stable clone using FACS(Cat# KB-1343,Kyinno).

Figure 3: Characterization of human GDF15 in the LLC-Luc2-GDF15 stable clone using PCR sequencing.

Cell Resuscitation

1. Prewarm culture medium (DMEM supplemented with 10% FBS, 1μg/mL puromycin and 500 μg/mL Hygromycin B)in a 37°C water bath.
2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
7. Incubate the flask at 37°C, 5% CO2 incubator.
8. Split saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
2. Keep the freezing medium on ice and label cryovials.
3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
6. Aliquot 1 mL of the cell suspension into each cryovial.
7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
8. Transfer vials to liquid nitrogen for long-term storage.

References

1. Sigvardsen CM, Richter MM, Engelbeen S, Kleinert M, Richter EA. GDF15 is still a mystery hormone. Trends Endocrinol Metab. 2024 Oct 29:S1043-2760(24)00254-6. doi: 10.1016/j.tem.2024.09.002. Epub ahead of print. PMID: 39472228.
2. Wang, D., Day, E.A., Townsend, L.K. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol 17, 592–607 (2021).
3. Conte M, Giuliani C, Chiariello A, Iannuzzi V, Franceschi C, Salvioli S. GDF15, an emerging key player in human aging. Ageing Res Rev. 2022 Mar;75:101569. doi: 10.1016/j.arr.2022.101569. Epub 2022 Jan 19. PMID: 35051643.